List of Tables
Table 1. Global GABAA Receptor Agonists Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global GABAA Receptor Agonists Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global GABAA Receptor Agonists Market Competitive Situation by Manufacturers in 2024
Table 4. Global GABAA Receptor Agonists Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global GABAA Receptor Agonists Sales Market Share by Manufacturers (2020-2025)
Table 6. Global GABAA Receptor Agonists Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global GABAA Receptor Agonists Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market GABAA Receptor Agonists Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of GABAA Receptor Agonists, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of GABAA Receptor Agonists, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of GABAA Receptor Agonists, Product Type & Application
Table 12. Global Key Manufacturers of GABAA Receptor Agonists, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global GABAA Receptor Agonists by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in GABAA Receptor Agonists as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global GABAA Receptor Agonists Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global GABAA Receptor Agonists Sales by Region (2020-2025) & (K Units)
Table 18. Global GABAA Receptor Agonists Sales Market Share by Region (2020-2025)
Table 19. Global GABAA Receptor Agonists Sales by Region (2026-2031) & (K Units)
Table 20. Global GABAA Receptor Agonists Sales Market Share by Region (2026-2031)
Table 21. Global GABAA Receptor Agonists Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global GABAA Receptor Agonists Revenue Market Share by Region (2020-2025)
Table 23. Global GABAA Receptor Agonists Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global GABAA Receptor Agonists Revenue Market Share by Region (2026-2031)
Table 25. North America GABAA Receptor Agonists Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America GABAA Receptor Agonists Sales by Country (2020-2025) & (K Units)
Table 27. North America GABAA Receptor Agonists Sales by Country (2026-2031) & (K Units)
Table 28. North America GABAA Receptor Agonists Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America GABAA Receptor Agonists Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe GABAA Receptor Agonists Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe GABAA Receptor Agonists Sales by Country (2020-2025) & (K Units)
Table 32. Europe GABAA Receptor Agonists Sales by Country (2026-2031) & (K Units)
Table 33. Europe GABAA Receptor Agonists Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe GABAA Receptor Agonists Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific GABAA Receptor Agonists Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific GABAA Receptor Agonists Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific GABAA Receptor Agonists Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific GABAA Receptor Agonists Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific GABAA Receptor Agonists Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America GABAA Receptor Agonists Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America GABAA Receptor Agonists Sales by Country (2020-2025) & (K Units)
Table 42. Latin America GABAA Receptor Agonists Sales by Country (2026-2031) & (K Units)
Table 43. Latin America GABAA Receptor Agonists Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America GABAA Receptor Agonists Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa GABAA Receptor Agonists Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa GABAA Receptor Agonists Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa GABAA Receptor Agonists Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa GABAA Receptor Agonists Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa GABAA Receptor Agonists Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global GABAA Receptor Agonists Sales (K Units) by Type (2020-2025)
Table 51. Global GABAA Receptor Agonists Sales (K Units) by Type (2026-2031)
Table 52. Global GABAA Receptor Agonists Sales Market Share by Type (2020-2025)
Table 53. Global GABAA Receptor Agonists Sales Market Share by Type (2026-2031)
Table 54. Global GABAA Receptor Agonists Revenue (US$ Million) by Type (2020-2025)
Table 55. Global GABAA Receptor Agonists Revenue (US$ Million) by Type (2026-2031)
Table 56. Global GABAA Receptor Agonists Revenue Market Share by Type (2020-2025)
Table 57. Global GABAA Receptor Agonists Revenue Market Share by Type (2026-2031)
Table 58. Global GABAA Receptor Agonists Price (US$/Unit) by Type (2020-2025)
Table 59. Global GABAA Receptor Agonists Price (US$/Unit) by Type (2026-2031)
Table 60. Global GABAA Receptor Agonists Sales (K Units) by Application (2020-2025)
Table 61. Global GABAA Receptor Agonists Sales (K Units) by Application (2026-2031)
Table 62. Global GABAA Receptor Agonists Sales Market Share by Application (2020-2025)
Table 63. Global GABAA Receptor Agonists Sales Market Share by Application (2026-2031)
Table 64. Global GABAA Receptor Agonists Revenue (US$ Million) by Application (2020-2025)
Table 65. Global GABAA Receptor Agonists Revenue (US$ Million) by Application (2026-2031)
Table 66. Global GABAA Receptor Agonists Revenue Market Share by Application (2020-2025)
Table 67. Global GABAA Receptor Agonists Revenue Market Share by Application (2026-2031)
Table 68. Global GABAA Receptor Agonists Price (US$/Unit) by Application (2020-2025)
Table 69. Global GABAA Receptor Agonists Price (US$/Unit) by Application (2026-2031)
Table 70. Pfizer Company Information
Table 71. Pfizer Description and Business Overview
Table 72. Pfizer GABAA Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Pfizer GABAA Receptor Agonists Product
Table 74. Pfizer Recent Developments/Updates
Table 75. Teva Company Information
Table 76. Teva Description and Business Overview
Table 77. Teva GABAA Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Teva GABAA Receptor Agonists Product
Table 79. Teva Recent Developments/Updates
Table 80. Torrent Pharma Company Information
Table 81. Torrent Pharma Description and Business Overview
Table 82. Torrent Pharma GABAA Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Torrent Pharma GABAA Receptor Agonists Product
Table 84. Torrent Pharma Recent Developments/Updates
Table 85. Roche Company Information
Table 86. Roche Description and Business Overview
Table 87. Roche GABAA Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Roche GABAA Receptor Agonists Product
Table 89. Roche Recent Developments/Updates
Table 90. Akorn Company Information
Table 91. Akorn Description and Business Overview
Table 92. Akorn GABAA Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Akorn GABAA Receptor Agonists Product
Table 94. Akorn Recent Developments/Updates
Table 95. Apotex Company Information
Table 96. Apotex Description and Business Overview
Table 97. Apotex GABAA Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Apotex GABAA Receptor Agonists Product
Table 99. Apotex Recent Developments/Updates
Table 100. Fresenius Kabi Company Information
Table 101. Fresenius Kabi Description and Business Overview
Table 102. Fresenius Kabi GABAA Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Fresenius Kabi GABAA Receptor Agonists Product
Table 104. Fresenius Kabi Recent Developments/Updates
Table 105. Hikma Company Information
Table 106. Hikma Description and Business Overview
Table 107. Hikma GABAA Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Hikma GABAA Receptor Agonists Product
Table 109. Hikma Recent Developments/Updates
Table 110. Mylan Company Information
Table 111. Mylan Description and Business Overview
Table 112. Mylan GABAA Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Mylan GABAA Receptor Agonists Product
Table 114. Mylan Recent Developments/Updates
Table 115. Sandoz Company Information
Table 116. Sandoz Description and Business Overview
Table 117. Sandoz GABAA Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Sandoz GABAA Receptor Agonists Product
Table 119. Sandoz Recent Developments/Updates
Table 120. Sun Pharma Company Information
Table 121. Sun Pharma Description and Business Overview
Table 122. Sun Pharma GABAA Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. Sun Pharma GABAA Receptor Agonists Product
Table 124. Sun Pharma Recent Developments/Updates
Table 125. WG Critical Care Company Information
Table 126. WG Critical Care Description and Business Overview
Table 127. WG Critical Care GABAA Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. WG Critical Care GABAA Receptor Agonists Product
Table 129. WG Critical Care Recent Developments/Updates
Table 130. Takeda Company Information
Table 131. Takeda Description and Business Overview
Table 132. Takeda GABAA Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. Takeda GABAA Receptor Agonists Product
Table 134. Takeda Recent Developments/Updates
Table 135. Shanghai Pharmaceuticals Holding Company Information
Table 136. Shanghai Pharmaceuticals Holding Description and Business Overview
Table 137. Shanghai Pharmaceuticals Holding GABAA Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 138. Shanghai Pharmaceuticals Holding GABAA Receptor Agonists Product
Table 139. Shanghai Pharmaceuticals Holding Recent Developments/Updates
Table 140. CHEPLAPHARM Company Information
Table 141. CHEPLAPHARM Description and Business Overview
Table 142. CHEPLAPHARM GABAA Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 143. CHEPLAPHARM GABAA Receptor Agonists Product
Table 144. CHEPLAPHARM Recent Developments/Updates
Table 145. Neurelis Company Information
Table 146. Neurelis Description and Business Overview
Table 147. Neurelis GABAA Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 148. Neurelis GABAA Receptor Agonists Product
Table 149. Neurelis Recent Developments/Updates
Table 150. Huazhong Pharmaceutical Company Information
Table 151. Huazhong Pharmaceutical Description and Business Overview
Table 152. Huazhong Pharmaceutical GABAA Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 153. Huazhong Pharmaceutical GABAA Receptor Agonists Product
Table 154. Huazhong Pharmaceutical Recent Developments/Updates
Table 155. Changzhou Siyao Pharmaceutical Company Information
Table 156. Changzhou Siyao Pharmaceutical Description and Business Overview
Table 157. Changzhou Siyao Pharmaceutical GABAA Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 158. Changzhou Siyao Pharmaceutical GABAA Receptor Agonists Product
Table 159. Changzhou Siyao Pharmaceutical Recent Developments/Updates
Table 160. SAGE Therapeutics Company Information
Table 161. SAGE Therapeutics Description and Business Overview
Table 162. SAGE Therapeutics GABAA Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 163. SAGE Therapeutics GABAA Receptor Agonists Product
Table 164. SAGE Therapeutics Recent Developments/Updates
Table 165. GSK Company Information
Table 166. GSK Description and Business Overview
Table 167. GSK GABAA Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 168. GSK GABAA Receptor Agonists Product
Table 169. GSK Recent Developments/Updates
Table 170. Sanofi Company Information
Table 171. Sanofi Description and Business Overview
Table 172. Sanofi GABAA Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 173. Sanofi GABAA Receptor Agonists Product
Table 174. Sanofi Recent Developments/Updates
Table 175. Sichuan HaiscoPharmaceuical Company Information
Table 176. Sichuan HaiscoPharmaceuical Description and Business Overview
Table 177. Sichuan HaiscoPharmaceuical GABAA Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 178. Sichuan HaiscoPharmaceuical GABAA Receptor Agonists Product
Table 179. Sichuan HaiscoPharmaceuical Recent Developments/Updates
Table 180. Novartis Company Information
Table 181. Novartis Description and Business Overview
Table 182. Novartis GABAA Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 183. Novartis GABAA Receptor Agonists Product
Table 184. Novartis Recent Developments/Updates
Table 185. AstraZeneca Company Information
Table 186. AstraZeneca Description and Business Overview
Table 187. AstraZeneca GABAA Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 188. AstraZeneca GABAA Receptor Agonists Product
Table 189. AstraZeneca Recent Developments/Updates
Table 190. Viatris Company Information
Table 191. Viatris Description and Business Overview
Table 192. Viatris GABAA Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 193. Viatris GABAA Receptor Agonists Product
Table 194. Viatris Recent Developments/Updates
Table 195. Key Raw Materials Lists
Table 196. Raw Materials Key Suppliers Lists
Table 197. GABAA Receptor Agonists Distributors List
Table 198. GABAA Receptor Agonists Customers List
Table 199. GABAA Receptor Agonists Market Trends
Table 200. GABAA Receptor Agonists Market Drivers
Table 201. GABAA Receptor Agonists Market Challenges
Table 202. GABAA Receptor Agonists Market Restraints
Table 203. Research Programs/Design for This Report
Table 204. Key Data Information from Secondary Sources
Table 205. Key Data Information from Primary Sources
Table 206. Authors List of This Report
List of Figures
Figure 1. Product Picture of GABAA Receptor Agonists
Figure 2. Global GABAA Receptor Agonists Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global GABAA Receptor Agonists Market Share by Type: 2024 & 2031
Figure 4. BZDs Product Picture
Figure 5. Non-BZDs Product Picture
Figure 6. Global GABAA Receptor Agonists Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global GABAA Receptor Agonists Market Share by Application: 2024 & 2031
Figure 8. Epilepsy
Figure 9. Insomnia
Figure 10. Anxiety
Figure 11. Neuropathic Pain
Figure 12. Other
Figure 13. Global GABAA Receptor Agonists Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global GABAA Receptor Agonists Market Size (2020-2031) & (US$ Million)
Figure 15. Global GABAA Receptor Agonists Sales (2020-2031) & (K Units)
Figure 16. Global GABAA Receptor Agonists Average Price (US$/Unit) & (2020-2031)
Figure 17. GABAA Receptor Agonists Report Years Considered
Figure 18. GABAA Receptor Agonists Sales Share by Manufacturers in 2024
Figure 19. Global GABAA Receptor Agonists Revenue Share by Manufacturers in 2024
Figure 20. Global 5 and 10 Largest GABAA Receptor Agonists Players: Market Share by Revenue in GABAA Receptor Agonists in 2024
Figure 21. GABAA Receptor Agonists Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 22. Global GABAA Receptor Agonists Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 23. North America GABAA Receptor Agonists Sales Market Share by Country (2020-2031)
Figure 24. North America GABAA Receptor Agonists Revenue Market Share by Country (2020-2031)
Figure 25. United States GABAA Receptor Agonists Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Canada GABAA Receptor Agonists Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. Europe GABAA Receptor Agonists Sales Market Share by Country (2020-2031)
Figure 28. Europe GABAA Receptor Agonists Revenue Market Share by Country (2020-2031)
Figure 29. Germany GABAA Receptor Agonists Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. France GABAA Receptor Agonists Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. U.K. GABAA Receptor Agonists Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Italy GABAA Receptor Agonists Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Russia GABAA Receptor Agonists Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Asia Pacific GABAA Receptor Agonists Sales Market Share by Region (2020-2031)
Figure 35. Asia Pacific GABAA Receptor Agonists Revenue Market Share by Region (2020-2031)
Figure 36. China GABAA Receptor Agonists Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Japan GABAA Receptor Agonists Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. South Korea GABAA Receptor Agonists Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. India GABAA Receptor Agonists Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Australia GABAA Receptor Agonists Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. China Taiwan GABAA Receptor Agonists Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Southeast Asia GABAA Receptor Agonists Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Latin America GABAA Receptor Agonists Sales Market Share by Country (2020-2031)
Figure 44. Latin America GABAA Receptor Agonists Revenue Market Share by Country (2020-2031)
Figure 45. Mexico GABAA Receptor Agonists Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Brazil GABAA Receptor Agonists Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Argentina GABAA Receptor Agonists Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Colombia GABAA Receptor Agonists Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Middle East and Africa GABAA Receptor Agonists Sales Market Share by Country (2020-2031)
Figure 50. Middle East and Africa GABAA Receptor Agonists Revenue Market Share by Country (2020-2031)
Figure 51. Turkey GABAA Receptor Agonists Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Saudi Arabia GABAA Receptor Agonists Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. UAE GABAA Receptor Agonists Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Global Sales Market Share of GABAA Receptor Agonists by Type (2020-2031)
Figure 55. Global Revenue Market Share of GABAA Receptor Agonists by Type (2020-2031)
Figure 56. Global GABAA Receptor Agonists Price (US$/Unit) by Type (2020-2031)
Figure 57. Global Sales Market Share of GABAA Receptor Agonists by Application (2020-2031)
Figure 58. Global Revenue Market Share of GABAA Receptor Agonists by Application (2020-2031)
Figure 59. Global GABAA Receptor Agonists Price (US$/Unit) by Application (2020-2031)
Figure 60. GABAA Receptor Agonists Value Chain
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
